Literature DB >> 32419410

Performance of SNAPPE-II score in neonatal sepsis: an experience from a tertiary care center.

Moumita Samanta1, Chiranjib Biswas2, Nishith Kumar Pal3, Soma Sarkar4, Avranil Goswami4, Avijit Hazra5, Arijit Bhowmik2, Tapas Kumar Sabui6.   

Abstract

BACKGROUND AND OBJECTIVES: The Score for Neonatal Acute Physiology II with Perinatal Extension (SNAPPE-II) is a vital tool for prognostication in newborns. The study was conducted with the hypothesis that the performance of the SNAPPE-II score might be affected by the presence of sepsis in newborns admitted with possible early onset septicemia and whether score performance varies between culture positive and culture negative sepsis.
METHODS: The prospective observational study was conducted over a period of 1 year (January 2014 to January 2015) in neonates presenting with clinical suspicion of sepsis to the Sick Newborn Care Unit (SNCU) of a tertiary care hospital in Eastern India.
RESULTS: SNAPPE-II score cut-off of ≥20 offered the highest sensitivity of 74.5% with specificity 48.3%, PPV 27.6% and NPV 87.7%. Comparison of mortality proportions between the two subgroups defined by this cut-off returned p= 0.005 with OR 3.47 (95% 1.40 to 8.64). No significant association was found between SNAPPE-II score and blood culture results; mean scores for culture positive (25.16 ± 15.6) and negative groups (24.49 ± 15.6) were comparable (p= 0.920).
CONCLUSIONS: At a cut-off value of ≥20 in presence of sepsis, SNAPPE-II score offers acceptable indices to predict mortality outcome. Prediction of outcome by SNAPPE-II score is not affected by positive or negative blood culture sepsis.

Entities:  

Keywords:  SNAPPE score; blood culture; neonatal sepsis

Year:  2020        PMID: 32419410     DOI: 10.24953/turkjped.2020.02.004

Source DB:  PubMed          Journal:  Turk J Pediatr        ISSN: 0041-4301            Impact factor:   0.552


  1 in total

1.  BCL-xL is correlated with disease severity in neonatal infants with early sepsis.

Authors:  Wu Wenshen; Peng Qi; Huang Tianli; Liao Jinfeng; Li Ning
Journal:  BMC Pediatr       Date:  2021-06-30       Impact factor: 2.125

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.